Baseline, Drug‐Related and Persistent Anemia and/or Thrombocytopenia Predict Responses and Prognosis in Myelofibrosis Patients Treated With Ruxolitinib

作者：Antonio Simone Laganà, Emilia Scalzulli, Ida Carmosino, Maria Laura Bisegna, S. Sorella, Claudia Ielo, Nadezda Zhdanovskaya, Maurizio Martelli, Massimo Breccia · 发表于：Hematological Oncology · 年份：2025 · DOI：10.1002/hon.70086 · 被引用次数：4 · 研究领域：Myeloproliferative Neoplasms: Diagnosis and Treatment、Chronic Myeloid Leukemia Treatments、Eosinophilic Disorders and Syndromes

The peer review history for this article is available at https://www.webofscience.com/api/gateway/wos/peer-review/10.1002/hon.70086. The data that support the findings of this study are available in the text and from the corresponding author, M.B., upon reasonable request. Please note: The publisher is not responsible for the content or functionality of any supporting information supplied by the authors. Any queries (other than missing content) should be directed to the corresponding author for the article.